Compound Management Market (2026 - 2033)

Compound Management Market Summary

The global compound management market size was valued at USD 840.3 million in 2025 and is projected to grow from USD 929.9 million in 2026 to USD 1,917.4 million by 2033, at a CAGR of 10.9% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 40.0% in 2025. Increasing drug discovery activities, growth in the pharmaceutical and biotechnology industries, and increasing demand for outsourcing these services are some of the key factors driving the market.

Market Dynamics

Type Insights

The products segment led the market with the largest revenue share of over 60.0% in 2025. The product segment is segmented into automated compound/sample storage systems, automated liquid handling systems, and other compound/sample storage systems. The growing demand for automation to manage the compound and libraries is expected to propel the segment growth. Plate stamping, compound tracking, and reformatting can all be accomplished with the use of an automated liquid handler and automated compound store equipment.

Automated storage systems improve overall efficiency and reliability, allowing users to focus on high-value activities. Many updated processes involve the complete integration of storage systems with sample-processing workstations that include pipetting robots. Smaller businesses can also benefit from system integration thanks to novel systems. The Verso automated storage system, for example, offers a variety of adjustable configurations to meet the changing needs of compound storage.

The service segment is expected to expand at the fastest CAGR during the forecast period. The rise in drug discovery activities, the growing need to manage compound management services, and the increasing need to save costs associated with drug discovery are some of the key factors fueling the growth of the service segment.

Over the years, the demand for outsourcing compound management services has improved as the pharma and biotech industries are focusing on core competencies and outsourcing non-core functions. A significant number of small and medium-sized companies lacking infrastructure for compound management is further expected to improve the demand for compound management outsourcing services, and thus is likely to have a positive impact on segment growth.

Application Insights

The drug discovery segment led the market with the largest revenue share of over 35.0% in 2025 and is projected to grow at a significant CAGR over the forecast period. Developing a drug is a costly, lengthy, and complicated process and requires various advanced techniques to check its process. High-throughput screening is used to screen a large number of compounds with a biological target. The data on activity against the target is collected from a broad library. Drug discovery is used to identify more active compounds. Hence, an increase in the activity of drug discovery is anticipated to create a great demand.

The bio-banking segment is anticipated to register at a lucrative CAGR during the forecast period owing to the increasing number of organizations involved in the collection and storage of biomaterials. In addition, an increasing emphasis on personalized medicine is driving the need for bio-banking. Besides, the need for high-quality biospecimens used to support research is expected to increase. Thus, the abovementioned factors are anticipated to support the growth of the segment.

End Use insights

The pharmaceutical companies segment led the market with the largest revenue share of over 34.0% in 2025, owing to the increasing drug discovery activity that is leading to an increased demand for the compounds, thereby positively affecting the market growth.

The biopharmaceutical companies segment is anticipated to exhibit at the fastest CAGR over the forecast period. Increased biologic production and the emergence of biosimilars are anticipated to propel the segment growth over the forecast period.

In addition, rising R&D investments in biopharmaceutical companies and the growing prevalence of chronic diseases will drive the segment.

Sample Type Insights

The chemical compounds segment led the market with the largest revenue share of over 52.0% in 2025. This is largely due to the large number of small-molecule compounds screened and assayed during drug discovery. Apart from this, a large number of chemicals are used in drug discovery and must be stored and managed throughout the process, further promoting segment growth.

The biosamples segment is anticipated to exhibit at the fastest CAGR over the forecast period. The increasing demand for personalized medicines is fueling the market growth. Biological samples are vital assets of medical research. Different biospecimens stored at biobanks are registering significant demand due to the developments in cell-based research activities. According to the FDA recommendations, the discovery and development of biomarkers are essential for biotechnology and pharmaceutical companies in the R&D process.

Regional Insights

North America dominated the global compound management market with the largest revenue share of over 40.9% in 2025. This is because many pharmaceutical and biotechnology firms are engaged in drug discovery in the region. As a result, there is an increasing demand for services in this region. Furthermore, the rise in disease-related morbidity and mortality has resulted in the identification of more drug candidates, fueling growth in this region. Favorable initiatives by public organizations for drug discovery and research are further promoting the regional market growth.

Asia Pacific Compound Management Market Trends

The compound management market in the Asia Pacific is expected to register at the fastest CAGR over the forecast period. Factors likely to propel regional market growth include ongoing drug discovery research, public-private collaborations, and government initiatives. Because of favorable government support, Japan contributed significantly to the market growth. The revised Pharmaceutical Affairs Law in Japan supports research activities in tissue diagnostics and cancer, which is expected to drive the market in this country in the near future. Furthermore, the low cost of outsourcing compound management services in the Asia Pacific countries and the high prevalence of chronic and infectious diseases in the region are driving the demand for research, thus contributing to regional growth.

Key Compound Management Company Insights

The compound management industry is highly competitive, and market players are undertaking numerous strategic initiatives, such as acquisitions, collaborations, and partnerships, to gain a greater market share.

Key Compound Management Companies

The following key companies have been profiled for this study on the global compound management market:

• Azenta US, Inc.

• Tecan Trading AG

• Hamilton Company

• BioAscent

• Titian Servis Indonesia

• Evotec SE

• Beckman Coulter Inc.

• LiCONiC AG

• AXXAM S.p.A.

• SPT Labtech Ltd

Recent Developments

• In August 2025, Genedata AG, a Danaher company, announced the launch of a newly designed module comprised in Genedata Biopharma Platform, enabling precise location tracking for physical samples across storage systems and sites.

• In January 2025, Azenta Life Sciences announced the opening of its latest biorepository facility in Massachusetts, U.S. Strategically located in the Greater Boston area to address requirements associated with biotech and pharmaceutical companies in Cambridge and Boston, this new facility is expected to strengthen its position in compound management and outsourced bio-banking and repository industry.
  

Compound Management Market Report Scope

Global Compound Management Market Report Segmentation

This report forecasts revenue growth at the regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global compound management market report based on the type, sample type, application, end-use, region,

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Product

    • Automated Compound/ Sample Storage System

    • Automated Liquid Handling Systems

    • Other Compound/ sample storage systems

  • Service

• Sample Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Chemical compound

  • Bio samples

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Drug Discovery

  • Gene Synthesis

  • Bio Banking

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Pharmaceutical

  • Biopharmaceutical

  • Contract Research Organizations

  • Others (Research and Institutes)

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • Italy

    • France

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Mexico

    • Brazil

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait